Interview with Stanislas Veillet on Boursier.com
Stanislas Veillet, CEO of Biophytis, analyses on BOURSIER.COM the new development cycle of Biophytis and reviews the clinical successes of the COVA, SARA, MYOCA and MACA studies which are in the Biophytis pipeline.